CDKN2A and osteogenesis imperfecta: Another difference is that fibroblasts from patients with lethal type VII OI had a normal level of CDKN2A transcripts, while fibroblasts from individuals with non-lethal type VII OI had a significantly lower expression level of the cell cycle inhibitor.